About the Event

SHAPING A HEALTHIER FUTURE

The Generative AI revolution is transforming the life sciences industry, driving unprecedented breakthroughs in drug discovery, clinical trials, and the development of personalized medicine—ultimately improving patient outcomes and delivering measurable ROI. This technological leap is empowering organizations to innovate faster, smarter, and more effectively.

Yet, as opportunities expand, challenges around governance, accessibility, and ethical implications remain critical to address.

Join top industry leaders and innovators at the Becker’s Life Sciences Virtual Event to explore the future of life sciences. Discover the cutting-edge advancements shaping medtech, pharmaceuticals, and more—and gain strategic insights to position your organization for leadership in this rapidly evolving landscape.

 

AGENDA TOPICS

  • Precision Medicine’s Next Wave: Genomics, Biomarkers, and Personalized Care
  • What's Next in Life Sciences? Big Growth Opportunities, AI and More
  • The Future of Life Sciences: Big Issues and Opportunities in the Next 3 Years

EVENT SPEAKERS


Sara Barrington
Chief Executive Officer
Verici Dx

Justin Brueck
MHA, MA
System Vice President, Innovation and Research
Endeavor Health

Ronald C. Carter
MHA
Director, Emerging Markets
Indivior

Manoja Lecamwasam
PhD, MBA
System Vice President, Intellectual Property, Life Sciences and MedDevice Strategic Innovation
CommonSpirit Health

Terry Myerson
Chief Executive Officer and Co-Founder
Truveta

Mohammed Quadri
MD, MBA
Vice President of Strategy, Academics, Research and Innovation
Hackensack Meridian Health